analyst
UN
NASDAQ · UNCY
Unicycive Therapeutics, Inc.
Healthcare · Biotechnology
$4.22
Down-$0.33 (-7.25%)
Updated Oct 5, 2026, 3:53 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 113.26M
- P/E ratio
- -3.47
- Dividend yield
- 0.00%
- 52-week range
- $3.93 – $8.74
- Volume
- 1.51M
- Avg. volume
- 458.61K
Price performance · UNCY
UNCY price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
UNCY closed at $4.22 after 19 trading sessions, down 16.10% for the selected period.
- Last close
- $4.22
- Period change
- -16.10%
- Period low
- $4.22
- Period high
- $5.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $4.62 | $4.62 | $4.09 | $4.22 | 1.51M |
| Oct 1, 2026 | $4.71 | $4.76 | $4.545 | $4.55 | 1.07M |
| Sep 30, 2026 | $4.61 | $4.81 | $4.5743 | $4.695 | 862.71K |
| Sep 29, 2026 | $4.66 | $4.70 | $4.28 | $4.55 | 2.31M |
| Sep 28, 2026 | $4.66 | $4.68 | $4.53 | $4.64 | 601.48K |
| Sep 25, 2026 | $4.83 | $4.85 | $4.66 | $4.695 | 495.05K |
| Sep 24, 2026 | $4.81 | $4.855 | $4.62 | $4.81 | 660.31K |
| Sep 23, 2026 | $4.94 | $4.96 | $4.73 | $4.81 | 771.82K |
| Sep 22, 2026 | $4.80 | $4.97 | $4.76 | $4.96 | 588.06K |
| Sep 21, 2026 | $4.85 | $4.85 | $4.7449 | $4.77 | 448.53K |
| Sep 18, 2026 | $4.80 | $4.85 | $4.76 | $4.80 | 1.11M |
| Sep 17, 2026 | $4.86 | $4.88 | $4.71 | $4.77 | 648.26K |
| Sep 16, 2026 | $4.85 | $4.90 | $4.6914 | $4.78 | 906.36K |
| Sep 15, 2026 | $5.15 | $5.15 | $4.71 | $4.71 | 1.69M |
| Sep 14, 2026 | $5.27 | $5.35 | $5.13 | $5.15 | 671K |
| Sep 11, 2026 | $5.34 | $5.40 | $5.22 | $5.29 | 1.12M |
| Sep 10, 2026 | $5.07 | $5.62 | $5.04 | $5.31 | 1.24M |
| Sep 9, 2026 | $5.03 | $5.14 | $5.01 | $5.12 | 906.97K |
| Sep 8, 2026 | $5.13 | $5.2199 | $5.025 | $5.03 | 817.18K |
Latest UNCY news
The latest Smart Investors Daily articles mentioning UNCY.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News
Loading stock research…